Bristol-Myers Squibb (BMY) Tops Q3 EPS by 26c, Beats on Revenue; Offers FY26 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $62.48 +1.78%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.35, $0.26 better than the analyst estimate of $1.09. Revenue for the quarter came in at $13.07 billion versus the consensus estimate of $12.72 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2026 EPS of $6.35-$6.55, versus the consensus of $6.49. Bristol-Myers Squibb sees FY2026 revenue of $49.75-50.25 billion, versus the consensus of $49.89 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- University Bancorp acquires remaining 20% of UIF for $15.2M
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
